Search Results - "Younoszai, Zahra"

Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver‐related mortality by Younossi, Zobair M., Stepanova, Maria, Rafiq, Nila, Makhlouf, Hala, Younoszai, Zahra, Agrawal, Ritambhara, Goodman, Zachary

“…Since the initial description of nonalcoholic steatohepatitis (NASH), several sets of pathologic criteria for its diagnosis have been proposed. However, their…”
Get full text

The changing landscape of hepatitis C virus therapy: focus on interferon-free treatment by Lam, Brian P., Jeffers, Thomas, Younoszai, Zahra, Fazel, Yousef, Younossi, Zobair M.

“…Chronic hepatitis C (CHC) affects over 185 million individuals worldwide, approximately 3% of the world’s population. CHC can lead to quality of life…”
Get full text

A Biomarker Panel for Non-alcoholic Steatohepatitis (NASH) and NASH-Related Fibrosis by Younossi, Zobair M., Page, Sandra, Rafiq, Nila, Birerdinc, Aybike, Stepanova, Maria, Hossain, Noreen, Afendy, Arian, Younoszai, Zahra, Goodman, Zachary, Baranova, Ancha

“…Background Patients with biopsy-proven NASH and especially those with fibrosis are at risk for progressive liver disease, emphasizing the clinical importance…”
Get full text

Hepatic sonic hedgehog protein expression measured by computer assisted morphometry significantly correlates with features of non-alcoholic steatohepatitis by Estep, Michael, Mehta, Rohini, Bratthauer, Gary, Alaparthi, Lakshmi, Monge, Fanny, Ali, Simon, Abdelatif, Dinan, Younoszai, Zahra, Stepanova, Maria, Goodman, Zachary D, Younossi, Zobair M

“…Hepatic expression of Sonic Hedgehog (SHH) is associated with Non-alcoholic fatty liver disease (NAFLD) and development of Non-alcoholic steatohepatitis…”
Get full text

Independent Predictors of Mortality and Resource Utilization in Viral Hepatitis Related Hepatocellular Carcinoma by Golabi, Pegah, Jeffers, Thomas, Younoszai, Zahra, Otgonsuren, Munkhzul, Sayiner, Mehmet, Mishra, Alita, Venkatesan, Chapy, Younossi, Zobair M

“…AbstractIntroductionHepatitis B (HBV) and C viruses (HCV) are important causes of hepatocellular carcinoma (HCC). Our aim was to assess mortality and resource…”
Get full text

An exploratory study examining how nano-liquid chromatography-mass spectrometry and phosphoproteomics can differentiate patients with advanced fibrosis and higher percentage collagen in non-alcoholic fatty liver disease by Younossi, Zobair M, Karrar, Azza, Pierobon, Mariaelena, Birerdinc, Aybike, Stepanova, Maria, Abdelatif, Dinan, Younoszai, Zahra, Jeffers, Thomas, Felix, Sean, Jeiran, Kianoush, Hodge, Alex, Zhou, Weidong, Monge, Fanny, Alaparthi, Lakshmi, Chandhoke, Vikas, Goodman, Zachary D, Petricoin, Emanuel F

“…Non-alcoholic steatohepatitis (NASH) is among the leading causes of liver disease worldwide. It is increasingly recognized that the phenotype of NASH may…”
Get full text

Impact of chronic liver disease and cirrhosis on health utilities using SF‐6D and the health utility index by Dan, Amy A., Kallman, Jillian B., Srivastava, Ragini, Younoszai, Zahra, Kim, Amy, Younossi, Zobair M.

“…Assessment of health‐related quality of life (HRQL) and health utilities have become important aspects of clinical research. Patient‐derived utility…”
Get full text

Statin use is not associated with liver related mortality by Younoszai, Zahra, Zheng, Li, Stepanova, Maria, Erario, Madeline, Cable, Rebecca, Younossi, Zobair M

“…AbstractBackground and Aim. Statins are commonly used medications for the treatment of dyslipidemia. Although there are reported cases of hepatotoxicity…”
Get full text

Association of Chronic Liver Disease with Depression: A Population-Based Study by Lee, Keanu, B.S, Otgonsuren, Munkhzul, M.S, Younoszai, Zahra, B.S, Mir, Heshaam M., M.D, Younossi, Zobair M., M.D., M.P.H

“…Objective Chronic liver diseases (CLD) have been associated with depression. Our aim was to assess the association of different types of CLD with depression in…”
Get full text

Predictors of All-Cause Mortality and Liver-Related Mortality in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) by Stepanova, Maria, Rafiq, Nila, Makhlouf, Hala, Agrawal, Ritambhara, Kaur, Ishmeet, Younoszai, Zahra, McCullough, Arthur, Goodman, Zachary, Younossi, Zobair M.

“…Aim Non-alcoholic steatohepatitis (NASH) patients are at increased risk for progression to cirrhosis. The aim of this study was to assess all-cause and…”
Get full text

Chronic kidney disease is independently associated with increased mortality in patients with nonalcoholic fatty liver disease by Paik, James, Golabi, Pegah, Younoszai, Zahra, Mishra, Alita, Trimble, Gregory, Younossi, Zobair M., Negro, Francesco

“…Background & Aims Nonalcoholic fatty liver disease and chronic kidney disease share similar pathophysiologic features. Our aim was to assess the association…”
Get full text

Mo1467 CAUSES OF CANCER DEATH IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD): DATA FROM RANCHO BERNARDO STUDY (RBS) by de Avila, Leyla, Paik, James M., Abedi, Rustin, Younoszai, Zahra, Weinstein, Ali A., Younossi, Zobair M.

Get full text

897 - Renal Impairment is an Extrahepatic Manifestation of Nonalcoholic Fatty Liver Disease (NAFLD) which is Independently Associated with Increased Mortality by Paik, James, Golabi, Pegah, Younoszai, Zahra, Mishra, Alita, Trimble, Gregory, Younossi, Zobair M.

Get full text

Performance of the Enhanced Liver Fibrosis Test to Estimate Advanced Fibrosis Among Patients With Nonalcoholic Fatty Liver Disease by Younossi, Zobair M, Felix, Sean, Jeffers, Thomas, Younossi, Elena, Nader, Fatema, Pham, Huong, Afendy, Arian, Cable, Rebecca, Racila, Andrei, Younoszai, Zahra, Lam, Brian P, Golabi, Pegah, Henry, Linda, Stepanova, Maria

“…The most important surrogate for increased risk of adverse clinical outcomes among patients with nonalcoholic fatty liver disease (NAFLD) is the patient's…”
Get full text

Markers of endothelial dysfunction in patients with non-alcoholic fatty liver disease and coronary artery disease by Elsheikh, Elzafir, Younoszai, Zahra, Otgonsuren, Munkhzul, Hunt, Sharon, Raybuck, Bryan, Younossi, Zobair M

“…Background Non‐alcoholic fatty liver disease (NAFLD) has been associated with coronary artery disease (CAD) and cardiac‐related mortality. Aim To assess the…”
Get full text

Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease by Karrar, Azza, Hariharan, Siddharth, Fazel, Yousef, Moosvi, Ali, Houry, Mohamad, Younoszai, Zahra, Jeffers, Thomas, Zheng, Li, Munkhzul, Otgonsuren, Hunt, Sharon, Monge, Fanny, Goodman, Zachary, Younossi, Zobair M.

“…The human leukocyte antigen (HLA) genes may play a role in the pathogenesis of non-alcoholic fatty liver disease (NAFLD) and its progressive form,…”
Get full text

1448-P: Enhanced Liver Fibrosis (ELF) Test Can Accurately Predict Advanced Fibrosis in Patients with Type 2 Diabetes and Nonalcoholic Fatty Liver Disease (NAFLD) by YOUNOSSI, ZOBAIR, FELIX, SEAN, JEFFERS, THOMAS, YOUNOSSI, ELENA, NADER, FATEMA, PHAM, HUONG, AFENDY, ARIAN, CABLE, REBECCA, RACILA, ANDREI, YOUNOSZAI, ZAHRA, LAM, BRIAN P., GOLABI, PEGAH, HENRY, LINDA, CLEMENT, STEPHEN, STEPANOVA, MARIA

“…Background: The ELF test (score calculated from markers of fibrosis: hyaluronic acid, procollagen III amino-terminal peptide, and tissue inhibitor of matrix…”
Get full text

Long-term outcomes of liver transplantation in patients with hepatitis C infection are not affected by HCV positivity of a donor by Stepanova, Maria, Sayiner, Mehmet, de Avila, Leyla, Younoszai, Zahra, Racila, Andrei, Younossi, Zobair M

“…The use of HCV-positive livers for HCV-positive recipients is becoming more common. Our aim is to evaluate long-term outcomes in liver transplant recipients…”
Get full text

230 - Hepatokines, Metalloproteases and their Tissue Inhibitors Provide Predictive Assessment for Liver Fibrosis in Nonalcoholic Fatty Liver Disease by Karrar, Azza, Rajput, Bijal, Barker, Katherine, Acosta, Katherine, Paik, James, Tan, Daisong, Younoszai, Zahra, Jeffers, Thomas, Felix, Sean C., Goodman, Zachary, Younossi, Zobair M.

Get full text

Circulating miRNA in patients with non-alcoholic fatty liver disease and coronary artery disease by Mehta, Rohini, Otgonsuren, Munkzhul, Younoszai, Zahra, Allawi, Hussain, Raybuck, Bryan, Younossi, Zobair

“…BackgroundNon-alcoholic fatty liver disease (NAFLD) is the hepatic manifestation of metabolic syndrome and coronary artery disease (CAD) is the cardiac…”
Get full text